The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (DD) - Consort Medical plc

13 Jan 2020 11:08

RNS Number : 6063Z
Consort Medical PLC
13 January 2020
 

FORM 8 (DD)

 

PUBLIC DEALING DISCLOSURE BY A PARTY TO AN OFFER OR PERSON ACTING IN CONCERT (INCLUDING DEALINGS FOR THE ACCOUNT OF DISCRETIONARY INVESTMENT CLIENTS)

Rules 8.1, 8.2 and 8.4 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Jonathan Glenn

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Consort Medical plc

(d) Status of person making the disclosure:

Person acting in concert with Consort Medical plc

(e) Date dealing undertaken:

7 January 2020

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing

 

Class of relevant security:

 

 

 

Interests

Short positions

Number(1)

%

Number

%

(1) Relevant securities owned and/or controlled:

183,790

0.372

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

TOTAL:

183,790

0.372

Nil

Nil

 

(1) Includes 118,101 shares held by Janis Glenn.

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

10p ordinary shares

Details, including nature of the rights concerned and relevant percentages:

 

Performance Share Plan 2015

Date of grant

Type of award

Number of shares under option

Exercise price

Exercise period

20 June 2017

Option

45,385

Nil

20 June 2020 - 19 June 2027

19 July 2018

Option

40,255

Nil

20 June 2023 - 18 July 2028

23 August 2019

Option

69,438

Nil

24 August 2024 - 22 August 2029

 

Deferred Bonus Plan 2010

Date of grant

Type of award

Number of shares under option

Exercise price

Exercise period

20 June 2017

Option

15,787

Nil

19 June 2020 - 29 July 2020

19 June 2018

Option

16,004

Nil

19 June 2021 - 29 July 2021

24 July 2019

Option

17,216

Nil

24 July 2022 - 2 September 2022

 

Sharesave

Date of grant

 

Type of award

Number of shares under option

Exercise price

Exercise period

24 July 2019

Option

1,162

£7.74

1 September 2022 - 28 February 2023

25 July 2017

Option

862

£10.44

1 September 2020 - 28 February 2021

 

 

 

3. DEALINGS BY THE PERSON MAKING THE DISCLOSURE

 

 

(a) Purchases and sales

 

(i) Party to an offer or person acting in concert (except for a principal trader in the same group as a connected adviser)

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

10p ordinary shares

Purchase

 

14

£10.299

 

(ii) Principal trader where the sole reason for the connection is that the principal trader is in the same group as a connected adviser

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

 

Nature of dealing

 

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

 

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

 

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

 

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer or person acting in concert making the disclosure and any other person:

 

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer or person acting in concert making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

13 January 2020

Contact name:

Andrew Jackson, Company Secretary

Telephone number:

+44 (0) 1442 867920

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DCCKKNBKDBKDQDD
Date   Source Headline
4th Dec 201911:39 amBUSForm 8.3 - CONSORT MEDICAL PLC
4th Dec 201911:10 amRNSForm 8.3 - Consort Medical plc
4th Dec 201910:52 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
3rd Dec 201912:24 pmRNSForm 8.3 - Consort Medical plc
3rd Dec 20199:56 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
3rd Dec 20199:46 amRNSForm 8.3 - Consort Medical plc
3rd Dec 20197:00 amRNSInterim Results
2nd Dec 20193:52 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Consort Medical PLC
2nd Dec 20193:20 pmRNSForm 8.3 - Consort Medical plc
2nd Dec 20193:14 pmRNSForm 8.3 - Consort Medical PLC
2nd Dec 20193:00 pmBUSFORM 8.3 - CONSORT MEDICAL PLC
2nd Dec 20199:47 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
29th Nov 20193:20 pmRNSForm 8.3 - Consort Medical plc
29th Nov 20193:03 pmRNSForm 8.3 - Consort Medical Plc
29th Nov 20192:59 pmRNSForm 8.3 - Consort Medical Plc
29th Nov 20192:58 pmRNSForm 8.3 - Consort Medical Plc
29th Nov 201912:17 pmRNSForm 8.3 - [Consort Medical plc]
29th Nov 20199:00 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
28th Nov 20192:32 pmGNWInvesco Ltd.: Form 8.3 - consort medical plc
28th Nov 20192:05 pmRNSForm 8.3 - Consort Medical Plc
28th Nov 201910:06 amRNSForm 8.3 - Consort Medical plc
28th Nov 20199:27 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
27th Nov 20194:18 pmRNSHolding(s) in Company
27th Nov 20193:13 pmRNSForm 8.3 -CONSORT Medical PLC
27th Nov 20192:10 pmRNSForm 8.3 - [Consort Medical plc]
27th Nov 201910:55 amRNSForm 8.3 - Consort Medical plc
27th Nov 201910:41 amRNSForm 8.3 - Consort Medical Plc
27th Nov 20199:04 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
26th Nov 201911:18 amRNSForm 8.3 - Consort Medical Plc
26th Nov 201910:07 amRNSForm 8.3 - Consort Medical Plc
26th Nov 20199:04 amGNWForm 8.5 (EPT/RI) - Consort Medical plc
26th Nov 20197:00 amRNSUpdate on Recipharm rights issue participation
25th Nov 20193:20 pmRNSForm 8.3 - Consort Medical plc
25th Nov 20192:44 pmGNWForm 8.3 - AXA INVESTMENT MANAGERS: Consort Medical PLC
25th Nov 20191:35 pmRNSForm 8.3 - Consort Medical Plc
25th Nov 20199:57 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
25th Nov 20198:00 amRNSNotice of Results
22nd Nov 20191:44 pmRNSForm 8.3 - Consort Medical Plc
22nd Nov 201912:16 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - Consort Medical plc - Ordinary shares
22nd Nov 201910:23 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
22nd Nov 20198:34 amRNSForm 8.3 - Consort Medical Plc
21st Nov 20192:26 pmRNSForm 8.3 - Consort Medical Plc
21st Nov 20191:33 pmRNSHolding(s) in Company
21st Nov 201912:11 pmRNSForm 8.3 - [Consort Medical plc]
21st Nov 201912:00 pmRNSForm 8.5 (EPT/RI) - Consort Medical Plc
21st Nov 201911:34 amGNWForm 8.5 (EPT/RI) - Consort Medical Plc
21st Nov 201910:12 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - Consort Medical plc - Ordinary shares
20th Nov 20194:23 pmRNSForm 8 (OPD) (Consort Medical plc)
20th Nov 20193:20 pmRNSForm 8.3 - Consort Medical plc
20th Nov 20193:00 pmBUSForm 8.3 - Consort Medical Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.